Saturday 21 December 2024
Internal Reference Number: FOI_6656
Date Request Received: 29/06/2022 00:00:00
Date Request Replied To: 04/07/2022 00:00:00
This response was sent via: By Email
Request Summary: Dabrafenib & Trametinib for cancer treatments
Request Category: Private Individuals
| Question Number 1: Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib: i) Metastatic Melanoma ii) Adjuvant Melanoma iii) BRAF mutated Lung Cancer | |
| Answer To Question 1: i) Metastatic Melanoma - 0 ii) Adjuvant Melanoma - 0 iii) BRAF mutated Lung Cancer - 0 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
